Ryan L Boudreau

Author PubWeight™ 12.90^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi.	Proc Natl Acad Sci U S A	2008	4.53
2	Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease.	Mol Ther	2011	1.72
3	Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4.	J Biol Chem	2011	1.26
4	Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice.	J Neurosci	2010	1.23
5	RNA interference: a tool for querying nervous system function and an emerging therapy.	Neuron	2007	1.00
6	Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice.	Mol Ther	2013	0.94
7	RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1.	Neurobiol Dis	2013	0.94
8	A microRNA processing defect in smokers' macrophages is linked to SUMOylation of the endonuclease DICER.	J Biol Chem	2014	0.87
9	Silencing of CDK5 as potential therapy for Alzheimer's disease.	Rev Neurosci	2011	0.83